NZE: FPH Statistics
Total Valuation
Fisher & Paykel Healthcare Corporation has a market cap or net worth of NZD 22.29 billion. The enterprise value is 22.32 billion.
Market Cap | 22.29B |
Enterprise Value | 22.32B |
Important Dates
The next estimated earnings date is Thursday, February 27, 2025.
Earnings Date | Feb 27, 2025 |
Ex-Dividend Date | Dec 5, 2024 |
Share Statistics
Fisher & Paykel Healthcare Corporation has 586.12 million shares outstanding. The number of shares has increased by 0.85% in one year.
Current Share Class | n/a |
Shares Outstanding | 586.12M |
Shares Change (YoY) | +0.85% |
Shares Change (QoQ) | +0.27% |
Owned by Insiders (%) | 0.39% |
Owned by Institutions (%) | 50.54% |
Float | 583.80M |
Valuation Ratios
The trailing PE ratio is 125.64 and the forward PE ratio is 56.02. Fisher & Paykel Healthcare Corporation's PEG ratio is 2.37.
PE Ratio | 125.64 |
Forward PE | 56.02 |
PS Ratio | 11.75 |
PB Ratio | 11.55 |
P/TBV Ratio | 12.07 |
P/FCF Ratio | 53.89 |
P/OCF Ratio | n/a |
PEG Ratio | 2.37 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 41.27, with an EV/FCF ratio of 53.98.
EV / Earnings | 125.07 |
EV / Sales | 11.81 |
EV / EBITDA | 41.27 |
EV / EBIT | 53.29 |
EV / FCF | 53.98 |
Financial Position
The company has a current ratio of 2.06, with a Debt / Equity ratio of 0.08.
Current Ratio | 2.06 |
Quick Ratio | 1.03 |
Debt / Equity | 0.08 |
Debt / EBITDA | 0.28 |
Debt / FCF | 0.36 |
Interest Coverage | 29.09 |
Financial Efficiency
Return on equity (ROE) is 9.70% and return on invested capital (ROIC) is 12.60%.
Return on Equity (ROE) | 9.70% |
Return on Assets (ROA) | 10.85% |
Return on Capital (ROIC) | 12.60% |
Revenue Per Employee | 269,850 |
Profits Per Employee | 25,482 |
Employee Count | 7,031 |
Asset Turnover | 0.78 |
Inventory Turnover | 2.15 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +59.05% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +59.05% |
50-Day Moving Average | 37.86 |
200-Day Moving Average | 34.40 |
Relative Strength Index (RSI) | 49.98 |
Average Volume (20 Days) | 346,767 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Fisher & Paykel Healthcare Corporation had revenue of NZD 1.89 billion and earned 178.50 million in profits. Earnings per share was 0.30.
Revenue | 1.89B |
Gross Profit | 1.15B |
Operating Income | 418.90M |
Pretax Income | 301.50M |
Net Income | 178.50M |
EBITDA | 522.10M |
EBIT | 418.90M |
Earnings Per Share (EPS) | 0.30 |
Balance Sheet
The company has 116.60 million in cash and 150.90 million in debt, giving a net cash position of -34.30 million or -0.06 per share.
Cash & Cash Equivalents | 116.60M |
Total Debt | 150.90M |
Net Cash | -34.30M |
Net Cash Per Share | -0.06 |
Equity (Book Value) | 1.93B |
Book Value Per Share | 3.29 |
Working Capital | 395.00M |
Cash Flow
In the last 12 months, operating cash flow was 506.10 million and capital expenditures -92.50 million, giving a free cash flow of 413.60 million.
Operating Cash Flow | 506.10M |
Capital Expenditures | -92.50M |
Free Cash Flow | 413.60M |
FCF Per Share | 0.71 |
Margins
Gross margin is 60.68%, with operating and profit margins of 22.16% and 9.44%.
Gross Margin | 60.68% |
Operating Margin | 22.16% |
Pretax Margin | 15.95% |
Profit Margin | 9.44% |
EBITDA Margin | 27.62% |
EBIT Margin | 22.16% |
FCF Margin | 21.88% |
Dividends & Yields
This stock pays an annual dividend of 0.42, which amounts to a dividend yield of 1.09%.
Dividend Per Share | 0.42 |
Dividend Yield | 1.09% |
Dividend Growth (YoY) | 2.44% |
Years of Dividend Growth | 12 |
Payout Ratio | 69.51% |
Buyback Yield | -0.85% |
Shareholder Yield | 0.24% |
Earnings Yield | 0.80% |
FCF Yield | 1.86% |
Stock Splits
The last stock split was on October 4, 2004. It was a forward split with a ratio of 5.
Last Split Date | Oct 4, 2004 |
Split Type | Forward |
Split Ratio | 5 |
Scores
Fisher & Paykel Healthcare Corporation has an Altman Z-Score of 21.13.
Altman Z-Score | 21.13 |
Piotroski F-Score | n/a |